Trexquant Investment LP Orchard Therapeutics PLC Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$3.86 - $5.07 $189,163 - $248,460	-49,006 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$4.11 - $6.45 $29,217 - $45,853	-7,109 Reduced 12.67%	49,006 $201,000
Q2 2020 Aug 07, 2020	BUY	$5.75 - $11.99 $322,661 - $672,818	56,115 New	56,115 $337,000
Q1 2020 May 08, 2020	SELL	$5.65 - $15.71 $61,867 - $172,024	-10,950 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$10.15 - $15.58 $111,142 - $170,601	10,950 New	10,950 $151,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.